𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study

✍ Scribed by Yoichi Ichikawa; Terunobu Saito; Hisashi Yamanaka; Masashi Akizuki; Hirobumi Kondo; Shigeto Kobayashi; Hisaji Oshima; Shinichi Kawai; Nobuaki Hama; Hidehiro Yamada; Tsuneyo Mimori; Koichi Amano; Yasushi Tanaka; Yasuo Matsuoka; Sumiki Yamamoto; Tsukasa Matsubara; Norikazu Murata; Tomiaki Asai; Yasuo Suzuki; MTX–BUC Combination Study Group,, Japanese Ministry of Health, Labour and Welfare's, “Research for Establishment of Therapeutic Guidelines in, Early Rheumatoid Arthritis”

Publisher
Springer
Year
2005
Tongue
English
Weight
226 KB
Volume
15
Category
Article
ISSN
1439-7595

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of infliximab and methotrexa
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial
✍ E. William St. Clair; Désirée M. F. M. van der Heijde; Josef S. Smolen; Ravinder 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

## Abstract ## Objective To compare the benefits of initiating treatment with methotrexate (MTX) and infliximab (anti–tumor necrosis factor α [anti‐TNFα] monoclonal antibody) with those of MTX treatment alone in patients with rheumatoid arthritis (RA) of ≤3 years' duration. ## Methods RA patient

Combination treatment with methotrexate,
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: An investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study
✍ Merete Lund Hetland; Kristian Stengaard-Pedersen; Peter Junker; Tine Lottenburge 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 2 views
A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled study of cd4 monoclonal antibody therapy in early rheumatoid arthritis
✍ Peter A. Van Der Lubbe; Ben A. C. Dijkmans; Hendrik M. Markusse; Ulla Nässander; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 920 KB

To assess the efficacy of the CD4 monoclonal antibody (MAb) cM-T412 in the treatment of early rheumatoid arthritis (RA). Methods. Sixty patients were enrolled in a 6-week randomized, double-blind, placebo-controlled study investigating multiple dose regimens of cM-T412. Thirty patients subsequently

Alefacept in combination with methotrexa
Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: Results of a randomized, double-blind, placebo-controlled study
✍ Philip J. Mease; Dafna D. Gladman; Edward C. Keystone 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and safety of alefacept in combination with methotrexate (MTX) for the treatment of psoriatic arthritis (PsA). ## Methods Patients were eligible for this randomized, double‐blind, placebo‐controlled trial if they were ages 18–70 years and had act